Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 276

1.

Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.

Xu Y, Pilla SJ, Alexander GC, Murimi IB.

PLoS One. 2019 Feb 13;14(2):e0211820. doi: 10.1371/journal.pone.0211820. eCollection 2019.

2.

Use of Population Pharmacokinetic Analyses Among FDA-Approved Biologics.

Ogasawara K, Alexander GC.

Clin Pharmacol Drug Dev. 2019 Feb 1. doi: 10.1002/cpdd.658. [Epub ahead of print]

PMID:
30707505
3.

Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults.

Pilla SJ, Segal JB, Alexander GC, Boyd CM, Maruthur NM.

J Am Geriatr Soc. 2019 Jan 31. doi: 10.1111/jgs.15790. [Epub ahead of print]

PMID:
30703251
4.

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers.

Heyward J, Jones CM, Compton WM, Lin DH, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket MC, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Oct 5;1(6):e183044. doi: 10.1001/jamanetworkopen.2018.3044.

5.

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.

Saloner B, Levin J, Chang HY, Jones C, Alexander GC.

JAMA Netw Open. 2018 Aug 3;1(4):e181588. doi: 10.1001/jamanetworkopen.2018.1588.

6.

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.

Lin DH, Jones CM, Compton WM, Heyward J, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket M, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Jun 1;1(2):e180235. doi: 10.1001/jamanetworkopen.2018.0235.

7.

Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014.

Daubresse M, Alexander GC, Crews DC, Segev DL, McAdams-DeMarco MA.

Am J Nephrol. 2019;49(1):20-31. doi: 10.1159/000495353. Epub 2018 Dec 13.

8.

Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016.

Alexander GC, Ogasawara K, Wiegand D, Lin D, Breder CD.

Ther Innov Regul Sci. 2018 Dec 3:2168479018812058. doi: 10.1177/2168479018812058. [Epub ahead of print]

PMID:
30509142
9.

Recent Progress in Vascular Tissue-Engineered Blood Vessels.

Chen J, Alexander GC, Bobba PS, Jun HW.

Adv Exp Med Biol. 2018;1064:123-144. doi: 10.1007/978-981-13-0445-3_8.

PMID:
30471030
10.

A More Balanced Approach to Dietary Supplement Data-Reply.

Qato DM, Alexander GC, Lindau ST.

JAMA Pediatr. 2018 Nov 12. doi: 10.1001/jamapediatrics.2018.4032. [Epub ahead of print] No abstract available.

PMID:
30419136
11.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Novick TK, Surapaneni A, Shin JI, Ballew SH, Alexander GC, Inker LA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8. No abstract available.

PMID:
30409899
12.

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.

Moore TJ, Zhang H, Anderson G, Alexander GC.

JAMA Intern Med. 2018 Nov 1;178(11):1451-1457. doi: 10.1001/jamainternmed.2018.3931.

PMID:
30264133
13.

Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users.

Murimi IB, Chang HY, Bicket M, Jones CM, Alexander GC.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):70-79. doi: 10.1002/pds.4639. Epub 2018 Sep 5.

PMID:
30187574
14.

Prescription Medication Use Among Children and Adolescents in the United States.

Qato DM, Alexander GC, Guadamuz JS, Lindau ST.

Pediatrics. 2018 Sep;142(3). pii: e20181042. doi: 10.1542/peds.2018-1042.

PMID:
30150214
15.

Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.

Chang HY, Singh S, Mansour O, Baksh S, Alexander GC.

JAMA Intern Med. 2018 Sep 1;178(9):1190-1198. doi: 10.1001/jamainternmed.2018.3034.

PMID:
30105373
16.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

PMID:
30039344
17.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

PMID:
30002224
18.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

Saloner B, Stoller KB, Alexander GC.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059. No abstract available.

19.

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.

Zhu J, Alexander GC, Nazarian S, Segal JB, Wu AW.

Pharmacotherapy. 2018 Sep;38(9):907-920. doi: 10.1002/phar.2158. Epub 2018 Jul 26.

PMID:
29920705
20.

Prevalence of Dietary Supplement Use in US Children and Adolescents, 2003-2014.

Qato DM, Alexander GC, Guadamuz JS, Lindau ST.

JAMA Pediatr. 2018 Aug 1;172(8):780-782. doi: 10.1001/jamapediatrics.2018.1008. No abstract available.

PMID:
29913013
21.

The Value of U.S. Pharmacopeial Standards: A Review of the Literature.

Heyward J, Padula W, Tierce JC, Alexander GC.

J Pharm Sci. 2018 Oct;107(10):2611-2617. doi: 10.1016/j.xphs.2018.06.004. Epub 2018 Jun 13.

PMID:
29908148
22.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

PMID:
29868840
23.

Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study.

Chang HY, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC.

BMC Med. 2018 May 16;16(1):69. doi: 10.1186/s12916-018-1058-y.

24.

Clinical trial registration and reporting: a survey of academic organizations in the United States.

Mayo-Wilson E, Heyward J, Keyes A, Reynolds J, White S, Atri N, Alexander GC, Omar A, Ford DE; National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee.

BMC Med. 2018 May 2;16(1):60. doi: 10.1186/s12916-018-1042-6.

25.

Opioid Oversupply After Joint and Spine Surgery: A Prospective Cohort Study.

Bicket MC, White E, Pronovost PJ, Wu CL, Yaster M, Alexander GC.

Anesth Analg. 2019 Feb;128(2):358-364. doi: 10.1213/ANE.0000000000003364.

PMID:
29677062
26.

Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.

Tieu C, Lucas EJ, DePaola M, Rosman L, Alexander GC.

PLoS One. 2018 Apr 18;13(4):e0195012. doi: 10.1371/journal.pone.0195012. eCollection 2018. Review.

27.

Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.

Baksh SN, McAdams-DeMarco M, Segal JB, Alexander GC.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):660-667. doi: 10.1002/pds.4437. Epub 2018 Apr 14.

PMID:
29655237
28.

High-Risk Prescription Opioid Use Among People Living With HIV.

Canan CE, Chander G, Monroe AK, Gebo KA, Moore RD, Agwu AL, Alexander GC, Lau B; HIV Research Network.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):283-290. doi: 10.1097/QAI.0000000000001690.

PMID:
29601405
29.

Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.

Chang HY, Murimi I, Faul M, Rutkow L, Alexander GC.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):422-429. doi: 10.1002/pds.4404. Epub 2018 Feb 28.

PMID:
29488663
30.

Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion.

Law E, Harrington R, Alexander GC, Saha S, Oehrlein E, Perfetto EM.

J Comp Eff Res. 2018 Feb;7(2):181-191. doi: 10.2217/cer-2017-0060. Epub 2018 Feb 21.

31.

Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States.

Jiao S, Murimi IB, Stafford RS, Mojtabai R, Alexander GC.

Pharmacotherapy. 2018 Apr;38(4):417-427. doi: 10.1002/phar.2095. Epub 2018 Mar 26.

PMID:
29457258
32.

Family caregivers' facilitation of daily adult prescription medication use.

Roter DL, Narayanan S, Smith K, Bullman R, Rausch P, Wolff JL, Alexander GC.

Patient Educ Couns. 2018 May;101(5):908-916. doi: 10.1016/j.pec.2017.12.018. Epub 2017 Dec 27.

PMID:
29352620
33.

Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.

Shin JI, Luo S, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

J Am Coll Cardiol. 2018 Jan 16;71(2):251-252. doi: 10.1016/j.jacc.2017.10.089. No abstract available.

34.

AuPb2I7: A Narrow Bandgap Au3+ Iodide Semiconductor.

Alexander GCB, Fabini DH, Seshadri R, Kanatzidis MG.

Inorg Chem. 2018 Jan 16;57(2):804-810. doi: 10.1021/acs.inorgchem.7b02723. Epub 2018 Jan 2.

35.

Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved Biologics.

Ogasawara K, Breder CD, Lin DH, Alexander GC.

Clin Ther. 2018 Jan;40(1):95-102.e2. doi: 10.1016/j.clinthera.2017.11.012. Epub 2017 Dec 19.

PMID:
29273471
36.

Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members.

Seamans MJ, Carey TS, Westreich DJ, Cole SR, Wheeler SB, Alexander GC, Pate V, Brookhart MA.

JAMA Intern Med. 2018 Jan 1;178(1):102-109. doi: 10.1001/jamainternmed.2017.7280.

37.

Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.

Tan J, Bae S, Segal JB, Zhu J, Alexander GC, Segev DL, McAdams-DeMarco M.

Nephrology (Carlton). 2019 Feb;24(2):234-244. doi: 10.1111/nep.13207.

PMID:
29219209
38.

Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.

Chang HY, Murimi IB, Jones CM, Alexander GC.

Addiction. 2018 Apr;113(4):677-686. doi: 10.1111/add.14068. Epub 2017 Nov 29.

PMID:
29193546
39.

Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.

Alexander GC, Schiman C, Kaestner R.

Med Care Res Rev. 2018 Apr;75(2):153-174. doi: 10.1177/1077558716681920. Epub 2016 Dec 1.

PMID:
29148319
40.

Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance.

Chang HY, Richards TM, Shermock KM, Elder Dalpoas S, J Kan H, Alexander GC, Weiner JP, Kharrazi H.

Med Care. 2017 Dec;55(12):1052-1060. doi: 10.1097/MLR.0000000000000825.

PMID:
29036011
41.

Branded prescription drug spending: a framework to evaluate policy options.

Ballreich J, Alexander GC, Socal M, Karmarkar T, Anderson G.

J Pharm Policy Pract. 2017 Oct 2;10:31. doi: 10.1186/s40545-017-0115-9. eCollection 2017.

42.

Automatable algorithms to identify nonmedical opioid use using electronic data: a systematic review.

Canan C, Polinski JM, Alexander GC, Kowal MK, Brennan TA, Shrank WH.

J Am Med Inform Assoc. 2017 Nov 1;24(6):1204-1210. doi: 10.1093/jamia/ocx066. Review.

PMID:
29016967
43.

Prescription drug monitoring program design and function: A qualitative analysis.

Rutkow L, Smith KC, Lai AY, Vernick JS, Davis CS, Alexander GC.

Drug Alcohol Depend. 2017 Nov 1;180:395-400. doi: 10.1016/j.drugalcdep.2017.08.040. Epub 2017 Sep 28.

PMID:
28978492
44.

The availability of pharmacies in the United States: 2007-2015.

Qato DM, Zenk S, Wilder J, Harrington R, Gaskin D, Alexander GC.

PLoS One. 2017 Aug 16;12(8):e0183172. doi: 10.1371/journal.pone.0183172. eCollection 2017.

45.

Reducing Branded Prescription Drug Prices: A Review of Policy Options.

Alexander GC, Ballreich J, Socal MP, Karmarkar T, Trujillo A, Greene J, Sharfstein J, Anderson G.

Pharmacotherapy. 2017 Nov;37(11):1469-1478. doi: 10.1002/phar.2013. Epub 2017 Oct 17. Review.

PMID:
28805961
46.

Prescription Opioid Analgesics Commonly Unused After Surgery: A Systematic Review.

Bicket MC, Long JJ, Pronovost PJ, Alexander GC, Wu CL.

JAMA Surg. 2017 Nov 1;152(11):1066-1071. doi: 10.1001/jamasurg.2017.0831. Review.

47.

Effect of Direct-to-Consumer Advertising on Statin Use in the United States.

Chang HY, Murimi I, Daubresse M, Qato DM, Emery SL, Alexander GC.

Med Care. 2017 Aug;55(8):759-764. doi: 10.1097/MLR.0000000000000752.

48.

Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.

Moyo P, Simoni-Wastila L, Griffin BA, Onukwugha E, Harrington D, Alexander GC, Palumbo F.

Addiction. 2017 Oct;112(10):1784-1796. doi: 10.1111/add.13860. Epub 2017 Jun 27.

PMID:
28498498
49.

Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists.

Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R.

Am J Emerg Med. 2017 Oct;35(10):1414-1419. doi: 10.1016/j.ajem.2017.04.023. Epub 2017 Apr 14.

50.

Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013.

Layton JB, Kim Y, Alexander GC, Emery SL.

JAMA. 2017 Mar 21;317(11):1159-1166. doi: 10.1001/jama.2016.21041.

Supplemental Content

Loading ...
Support Center